STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2025

Equity [Abstract]

Summary of Stock Option Activity

The following table summarizes the changes in the Company’s outstanding stock options for the three months ended March 31, 2025:

	Number of Options
Outstanding at January 1, 2025		18,396,536
Granted (1)		111,500
Exercised		(41,390	)
Forfeited / Cancelled / Expired		(512,400	)
Outstanding at March 31, 2025		17,954,246

_____________________________________________

(1) Consists of new hire employee grants of stock options to purchase 111,500 shares of the Company's Class A common stock. The grants vest 25% on the first anniversary date of the grant with the remainder vesting equally over the remaining 36 months, subject to the employee’s continued service to the Company through the applicable vesting dates.

Summary of Restricted Stock Unit Activity

The following table summarizes the changes in the Company’s outstanding RSUs for the three months ended March 31, 2025:

	Number of RSUs
Outstanding at January 1, 2025		138,902
Granted (1)		2,341,853
Vested		(29,143	)
Forfeited		(9,629	)
Outstanding at March 31, 2025		2,441,983

_____________________________________________

(1) Includes new hire grants of 8,520 RSUs, annual employee grants of 1,733,333 RSUs, and grants to executive officers of 600,000 RSUs. The grants will vest 25% approximately on the anniversary date of the grant with the remainder vesting equally over the remaining 12 quarters, subject to the employee’s continued service to the Company through the applicable vesting dates.

Summary of Stock-Based Compensation Expenses by Function

The following table presents details of stock-based compensation expenses by functional line item noted within the Company's operating expenses:

	Three Months Ended March 31,
	2025		2024
Cost of sales	$	18	$	24
Research and development		345		337
Sales and marketing		63		39
General and administrative		519		632
	$	945	$	1,032